No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MRVI240621P10000
- 3.30
- +2.65+407.69%
15min DelayClose Jun 20 16:00 ET
3.30High3.30Low
3.30Open0.65Pre Close6 Volume506 Open Interest10.00Strike Price1.98KTurnover424.84%IV4.42%PremiumJun 21, 2024Expiry Date2.99Intrinsic Value100Multiplier1DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type-0.9130Delta0.0943Gamma2.30Leverage Ratio-0.0600Theta-0.0003Rho-2.10Eff Leverage0.0006Vega
Intraday
- 5D
- Daily
News
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient to Support
Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best
Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter financial results.Bank of Montreal posted quarterly adjusted
Maravai LifeSciences Shares Fall 16% After Stock-Sale Proposals
By Ben Glickman Shares of Maravai LifeSciences Holdings fell Wednesday after the company registered to sell nearly 10 million shares. The stock was down 16%, to $9.04, in afternoon trading. Shares a
Comments
Despite Maravai LifeSciences Holdings' significant liabilities, it has net cash, indicating a light debt load. However, its pre-interest and tax loss and declining revenue raise future earnings and balance sheet health concerns.
Is Maravai LifeSciences Holdings (NASDAQ:MRVI) Using Debt In A Risky Way? 1
While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.
While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.
While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.
While Maravai LifeSciences Holdings displays a low ROE, its ability to expand net income considerably due to efficient management and high profit reinvestment is a positive sign. Current analyst forecasts suggest continued earnings growth for the company.
Read more